Obstetrics, gynecology, andrology, sexual and reproductive health

Menstruation disturbances, female gonadal disorders

PubMed Free Full Text

Hyperprolactinemia, galactorrhea

 

Australia

• Australian Prescriber
  • Hyperprolactinaemia [2017]

Austria, Germany, Switzerland

• European Archives of Psychiatry and Clinical Neuroscience
  • Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015 [2021]

Brazil

• Archives of Endocrinology and Metabolism
  • Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism [2018]

Croatia

• Endocrine Oncology and Metabolism
  • Croatian guidelines for the management of hyperprolactinemia: a viewpoint from a developing country [2015]

High-income countries

• Frontiers in Endocrinology
  • The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis [2023]

International

• International Journal of Environmental Research and Public Health
  • Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis [2020]

• Pharmaceutical Medicine
  • Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review [2023]

Italy

• European Journal of Endocrinology
  • Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors [2022]

Spain

• Endocrinología y Nutrición (English Edition)
  • Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia [2013]

• Revista de Psiquiatría y Salud Mental
  • Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia [2016]

Turkey

• Journal of Clinical Research in Pediatric Endocrinology
  • Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey [2019]

United States

• Endocrine Society
  • Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline [2011]

• National Cancer Institute
  • Pituitary Tumors Treatment (PDQ®)

WHO

• World Health Organization
  • Application for inclusion of Bromocriptine and Cabergoline In the WHO Model Lists of Essential Medicines (2023) for Adults and Children [2022]
  • WHO International collaborative study of the proposed 4th International Standard for Prolactin, Human [2016]

{Related topics}

• Guidelines
  • Amenorrhea